Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02893917
Title Olaparib With or Without Cediranib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate adenocarcinoma

Therapies

Cediranib + Olaparib

Olaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
University of California Davis Comprehensive Cancer Center Sacramento California 95817 United States Details
UC San Diego Medical Center - Hillcrest San Diego California 92103 United States Details
Smilow Cancer Center/Yale-New Haven Hospital New Haven Connecticut 06510 United States Details
Yale University New Haven Connecticut 06520 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field